Nonablative Fractional 1,550-nm Laser for the Treatment of an Unusual Nevus Sebaceus.

Dermatol Surg

Dermatology and Laser Surgery Center, Houston, Texas West Lake Dermatology, Austin, Texas Dermatology and Laser Surgery Center, Houston, Texas.

Published: December 2019

Download full-text PDF

Source
http://dx.doi.org/10.1097/DSS.0000000000001768DOI Listing

Publication Analysis

Top Keywords

nonablative fractional
4
fractional 1550-nm
4
1550-nm laser
4
laser treatment
4
treatment unusual
4
unusual nevus
4
nevus sebaceus
4
nonablative
1
1550-nm
1
laser
1

Similar Publications

Background: The non-ablative 1940-nm laser induces controlled thermal damage at superficial depths without ablating the epidermis.

Objective: We evaluated a new 1940-nm fractional diode laser for improving pigmentation and skin texture.

Materials And Methods: Participants with mild to severe benign pigmented lesions received up to three laser treatments.

View Article and Find Full Text PDF

Background: The use of non-ablative fractionated lasers for skin rejuvenation has been proven to be effective in improving skin texture, and has become popular due to minimal wounding, significantly shorter recovery times and decreased adverse effects.

Objective: To retrospectively analyze improvement in skin texture in healthy women aged over 18 years with Fitzpatrick skin type II-IV.

Methods: Participants received 3 facial and/or neck treatments with the 1570-nm fractional scanning diode laser at one-month intervals.

View Article and Find Full Text PDF

Background: Acne scarring can have a detrimental impact on quality of life, making early and effective treatment essential. Lasers and energy-based treatment are the preferred treatment modality, yet a clear consensus on the ideal laser selection is lacking in the literature.

Aims: This review article aims to describe the therapeutic potential of lasers for acne scarring with a focus on clinical trials involving atrophic facial acne scars.

View Article and Find Full Text PDF

Keloid Formation and Any Skin Complications in Patients Treated With Isotretinoin and Undergone Any Skin-Related Procedures.

J Cosmet Dermatol

November 2024

Department of Dermatology, Rasool Akram Medical Complex Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.

Background: Isotretinoin is widely used for moderate to severe acne vulgaris. Despite its broad application, isotretinoin carries a risk of permanent scarring and keloid formation following various skin procedures. As a result, a delay of at least 6-12 months after completing or discontinuing isotretinoin treatment is commonly recommended before undergoing skin procedures.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!